| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.48▲ | 1.50▼ | 1.50▼ | 1.56▼ | 1.86▼ |
| MA10 | 1.51▼ | 1.52▼ | 1.52▼ | 1.65▼ | 1.68▼ |
| MA20 | 1.52▼ | 1.54▼ | 1.56▼ | 1.86▼ | 2.06▼ |
| MA50 | 1.56▼ | 1.58▼ | 1.63▼ | 1.69▼ | 3.72▼ |
| MA100 | 1.58▼ | 1.68▼ | 1.79▼ | 2.16▼ | N/A |
| MA200 | 1.68▼ | 1.90▼ | 1.69▼ | 3.33▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.005▼ | -0.004▼ | -0.044▼ | 0.057▲ |
| RSI | 39.976▼ | 36.645▼ | 37.648▼ | 39.865▼ | 36.773▼ |
| STOCH | 12.619▼ | 23.333 | 17.300▼ | 12.538▼ | 31.378 |
| WILL %R | -83.333▼ | -83.333▼ | -93.182▼ | -95.890▼ | -81.313▼ |
| CCI | -71.687 | -141.766▼ | -105.718▼ | -107.562▼ | -65.877 |
|
Friday, August 15, 2025 09:21 AM
TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to reverse biological aging and ...
|
|
Wednesday, August 13, 2025 05:34 AM
Ooma, Inc. (NYSE: OOMA), a smart communications platform for businesses and consumers, today announced the following conference participation: ...
|
|
Monday, August 11, 2025 03:54 PM
New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential to treat cancer, autoimmune conditions, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.52 | 1.56 | 1.46 | 1.49 | 435,700 |
| 14/08/25 | 1.60 | 1.65 | 1.50 | 1.57 | 652,688 |
| 13/08/25 | 1.53 | 1.78 | 1.52 | 1.60 | 641,600 |
| 12/08/25 | 1.54 | 1.58 | 1.51 | 1.55 | 127,300 |
| 11/08/25 | 1.56 | 1.62 | 1.54 | 1.58 | 193,000 |
| 08/08/25 | 1.70 | 1.74 | 1.51 | 1.56 | 512,670 |
| 07/08/25 | 1.85 | 1.88 | 1.61 | 1.67 | 425,800 |
| 06/08/25 | 1.82 | 1.84 | 1.7655 | 1.84 | 220,933 |
| 05/08/25 | 1.79 | 1.8702 | 1.78 | 1.83 | 161,410 |
| 04/08/25 | 1.78 | 1.89 | 1.7506 | 1.83 | 247,041 |
|
|
||||
|
|
||||
|
|